Johnson & Johnson Current Ratio 2006-2018 | JNJ

Current and historical current ratio for Johnson & Johnson (JNJ) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Johnson & Johnson current ratio for the three months ending June 30, 2018 was 1.65.
Johnson & Johnson Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-06-30 $45.44B $27.49B 1.65
2018-03-31 $42.77B $27.08B 1.58
2017-12-31 $43.09B $30.54B 1.41
2017-09-30 $41.83B $31.81B 1.32
2017-06-30 $38.79B $28.87B 1.34
2017-03-31 $63.35B $25.12B 2.52
2016-12-31 $65.03B $26.29B 2.47
2016-09-30 $63.32B $23.23B 2.73
2016-06-30 $66.29B $21.54B 3.08
2016-03-31 $62.74B $22.13B 2.83
2015-12-31 $60.21B $27.75B 2.17
2015-09-30 $63.49B $25.26B 2.51
2015-06-30 $61.00B $24.51B 2.49
2015-03-31 $58.19B $23.84B 2.44
2014-12-31 $55.74B $25.03B 2.23
2014-09-30 $59.97B $22.98B 2.61
2014-06-30 $60.12B $24.36B 2.47
2014-03-31 $57.37B $23.84B 2.41
2013-12-31 $56.41B $25.68B 2.20
2013-09-30 $52.18B $25.84B 2.02
2013-06-30 $51.27B $23.77B 2.16
2013-03-31 $47.23B $22.52B 2.10
2012-12-31 $46.12B $24.26B 1.90
2012-09-30 $44.79B $23.94B 1.87
2012-06-30 $41.62B $23.85B 1.75
2012-03-31 $57.01B $21.20B 2.69
2011-12-31 $54.32B $22.81B 2.38
2011-09-30 $53.44B $21.69B 2.46
2011-06-30 $52.67B $20.99B 2.51
2011-03-31 $49.22B $24.01B 2.05
2010-12-31 $47.31B $23.07B 2.05
2010-09-30 $42.72B $17.41B 2.45
2010-06-30 $39.02B $17.16B 2.27
2010-03-31 $38.86B $18.50B 2.10
2009-12-31 $39.54B $21.73B 1.82
2009-09-30 $35.60B $19.25B 1.85
2009-06-30 $35.49B $19.89B 1.79
2009-03-31 $34.84B $21.33B 1.63
2008-12-31 $34.38B $20.85B 1.65
2008-09-30 $36.59B $22.73B 1.61
2008-06-30 $35.82B $21.78B 1.64
2008-03-31 $33.82B $22.07B 1.53
2007-12-31 $29.95B $19.84B 1.51
2007-09-30 $28.94B $19.33B 1.50
2007-06-30 $25.80B $18.98B 1.36
2007-03-31 $24.67B $19.66B 1.26
2006-12-31 $22.98B $19.16B 1.20
2006-09-30 $31.29B $12.06B 2.59
2006-06-30 $31.51B $12.19B 2.59
2006-03-31 $33.75B $13.19B 2.56
2005-12-31 $31.48B $12.64B 2.49
2005-09-30 $30.58B $12.05B 2.54
2005-06-30 $28.72B $11.64B 2.47
2005-03-31 $28.77B $12.98B 2.22
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $359.375B $76.450B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $256.688B 15.02
Novartis AG (NVS) Switzerland $192.696B 16.53
Merck (MRK) United States $187.277B 16.54
AbbVie (ABBV) United States $135.043B 13.19
Eli Lilly (LLY) United States $118.805B 21.99
Sanofi (SNY) France $108.926B 13.79
Novo Nordisk (NVO) Denmark $103.361B 16.52
GlaxoSmithKline (GSK) United Kingdom $96.420B 12.87
AstraZeneca (AZN) United Kingdom $94.908B 10.44
Bristol-Myers Squibb (BMY) United States $94.166B 17.04